Activoris received the manufacturing and import license for secondary packaging of clinical samples. The authorization includes non-sterile drugs, biologicals, human or animal extracted products, hormones, prostaglandins, cytokines as well as immune-suppressives for phase I, II, and III clinical trials. Your trial is a challenging project, rely on our expertise to establish the right strategy regarding to purchasing, kit configuration and supply to your study centers.
Flexible Project Support, Partner-Network for primary packaging
Kit Configurations, Booklets, Package Inserts
Cooling Capacities 2 – 8 °C, Hazardous Substances
Packaging and Labeling, Kit Assembly
QP Release, GMP compliant Conduct and Documentation
Storage and Distribution
Today, the requirements for clinical trials gain more importance in view of the approval of innovative devices. However, a CE-marking or a 510(k) clearance is not enough to achieve sales. The increasing price pressure calls for a superior differentiation. Meaning, obtaining re-imbursement requires to effectively demonstrate superior performance of your device. Our medtech and pharma experience of multiple clinical developments and a specialized provider network navigate you through this important development step.